Kelly A. Schwartz

Seizure Incidence in Psychopharmacological Clinical Trials: An Analysis of Food and Drug Administration (FDA) Summary Basis of Approval Reports

Russell L. Kolts, Kenneth Alper, K. Alper, 2007, Biological Psychiatry.

Relationship Between Depression Severity Entry Criteria and Antidepressant Clinical Trial Outcomes

Russell L. Kolts, C. Lineberry, Arif Khan, 2007, Biological Psychiatry.

BMI, sex, and antidepressant response.

W. Brown, Arif Khan, Kelly A. Schwartz, 2007, Journal of affective disorders.

Sex Differences in Antidepressant Response in Recent Antidepressant Clinical Trials

W. Brown, Arif Khan, Kelly A. Schwartz, 2005, Journal of clinical psychopharmacology.

Study designs and outcomes in antidepressant clinical trials.

Arif Khan, Arif Khan, Kelly A. Schwartz, 2005, Essential psychopharmacology.

Psychiatric Diagnosis and Clinical Trial Completion Rates: Analysis of the FDA SBA Reports

W. Brown, Arif Khan, Kelly A. Schwartz, 2007, Neuropsychopharmacology.

ADHD and Stroop interference from age 9 to age 41 years: a meta-analysis of developmental effects

P. Verhaeghen, Kelly A. Schwartz, K. Schwartz, 2008, Psychological Medicine.

Suicide risk and symptom reduction in patients assigned to placebo in duloxetine and escitalopram clinical trials: analysis of the FDA summary basis of approval reports.

Arif Khan, Kelly A. Schwartz, K. Schwartz, 2007, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

Mortality risk in patients with schizophrenia participating in premarketing atypical antipsychotic clinical trials.

W. Brown, Arif Khan, D. Robinson, 2007, The Journal of clinical psychiatry.